Mycapssa Capsule, Delayed Release
Product Images NDC 10122-550

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Mycapssa (NDC 10122-550). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chiesi Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Mycapssa 1)

Formula (Mycapssa 1)
Chemical structure of the active ingredient octreotide, depicting the amino acid sequence and molecular components with a variable side chain denoted by x ranging from 1.4 to 2.5.*
FDA Label Image

Figure A (Mycapssa 2)

Figure A (Mycapssa 2)
Illustration showing a three-step process to open a medication pack. Step 1 involves pushing a part of the pack, Step 2 is pulling to extend it, and Step 3 is unfolding the pack to access the capsules inside.*
FDA Label Image

Figure B (Mycapssa 3)

Figure B (Mycapssa 3)
An instructional illustration showing how to properly push a capsule out of a blister pack using the tip of the thumb. It includes warnings not to use two thumbs or press the middle of a capsule to avoid improper removal.*
FDA Label Image

Blister Pack (Mycapssa 4)

Blister Pack (Mycapssa 4)
Packaging label for Mycapssa 20 mg delayed-release capsules, featuring a blue and orange color scheme. The label indicates a count of 28 capsules per package and includes storage instructions. It also displays the NDC 10122-550-28 and notes the product is by Chiesi USA, Inc., manufactured in Parma, Italy, with M&W Encap Ltd. in Scotland as the capsule manufacturer.*
FDA Label Image

Blister Dose Pack (Mycapssa 5)

Blister Dose Pack (Mycapssa 5)
Mycapssa 20 mg delayed-release capsules packaging label by Chiesi USA, Inc. The label states the product name, generic name Octreotide, dosage form as delayed-release capsules, and strength 20 mg. It includes directions for use, storage instructions, a barcode, and spaces for pharmacy labeling and lot/expiration information. The design features a combination of white, blue, and orange colors, with usage instructions depicted graphically.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.